Development of a novel vaccine delivery system based on Gantrez nanoparticles.

scientific article published in September 2006

Development of a novel vaccine delivery system based on Gantrez nanoparticles. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1166/JNN.2006.471
P698PubMed publication ID17048548
P5875ResearchGate publication ID6746246

P50authorMarta FerrerQ50214534
Christine VauthierQ51042415
P2093author name stringSara Gómez
Carlos Gamazo
Beatriz San Roman
Juan M Irachel
P433issue9-10
P407language of work or nameEnglishQ1860
P921main subjectnanoparticleQ61231
P304page(s)3283-3289
P577publication date2006-09-01
P1433published inJournal of Nanoscience and NanotechnologyQ2364336
P1476titleDevelopment of a novel vaccine delivery system based on Gantrez nanoparticles.
P478volume6

Reverse relations

cites work (P2860)
Q49081384Adjuvant effect of Gantrez®AN nanoparticles during oral vaccination of piglets against F4+enterotoxigenic Escherichia coli
Q39151158Adjuvants for allergy immunotherapeutics.
Q37635409Aluminum-phthalocyanine chloride associated to poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as a new third-generation photosensitizer for anticancer photodynamic therapy
Q34976931Critical evaluation of biodegradable polymers used in nanodrugs
Q57216501Gantrez AN nanoparticles as an adjuvant for oral immunotherapy with allergens
Q34057755Immunogenicity of peanut proteins containing poly(anhydride) nanoparticles
Q84938205Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice
Q39294509Nanomaterials in the Context of Type 2 Immune Responses-Fears and Potentials.
Q37890639Nanomedicine: novel approaches in human and veterinary therapeutics
Q38257645Nanoparticle based-immunotherapy against allergy.
Q33834985Nanoparticle-allergen complexes for allergen immunotherapy.
Q43623067Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice
Q36968297Nanoparticles and microparticles as vaccine-delivery systems
Q26825418Nanoparticulate adjuvants and delivery systems for allergen immunotherapy
Q47410379Oral immunotherapy using polymeric nanoparticles loaded with peanut proteins in a murine model of fatal anaphylaxis.
Q42117985Poly(anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation
Q84301195Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators
Q33282108Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice.

Search more.